Predictive value of aorta enhancement on computed tomographic pulmonary angiography in pulmonary embolism

Abstract

Background Pulmonary embolism (PE) is a life-threatening condition requiring prompt diagnosis and treatment. Visual assessment of computed tomographic pulmonary angiography (CTPA) is the first-choice diagnostic tool. New imaging biomarkers could provide additional prognostic information for improved risk stratification. We hypothesized in this exploratory study, that contrast enhancement patterns in the aorta may contain such information. Methods CTPA scans of 93 acute PE patients were analyzed retrospectively. Firstly, the aorta was segmented automatically by TotalSegmentator and its centerline was extracted. Subsequently, lines were fitted on intensities within a region of interest perpendicularly to the aorta centerline, from which three parameters were extracted: mean intensity, proximal intensity and contrast gradient. After confounder analysis, logistic regression with forward selection evaluated the predictive value of these parameters for 12 adverse outcomes (six short-term and six long-term). Results Lung volume, aorta dimension and contrast delay were considered as possible confounders but were not selected by forward selection. Logistic regression (n = 93) showed that a less steep contrast gradient (decreasing by 10 Hounsfield unit/%) was associated with a reduction in odds of the following short-term adverse outcomes: 48.1% for intensive care unit admission (odds ratio [OR] = 0.519, 95% confidence interval [CI]: 0.306–0.804), 29.3% for oxygen therapy >24 hours (OR = 0.707, 95% CI: 0.496–0.976), 60.6% for reperfusion therapy (OR = 0.394, 95% CI: 0.178–0.682), 57.5% for vasopressor therapy (OR = 0.425, 95% CI: 0.194–0.741), and 50.2% for PE-related death (OR = 0.498, 95% CI: 0.246–0.915). No significant associations were found with long-term outcomes. Conclusions The aorta contrast gradient, automatically quantified from CTPA, is a relevant adjunctive predictor for short-term outcomes in PE patients. Long-term outcomes, however, could not be predicted by aorta measurement. This pilot study provides initial insights into predictive value of aorta enhancement, stimulating further exploration with external data.